drug · small molecule
METHOTREXATE
Phase 2updated 6mo agoby $ALDX Aldeyra Therapeutics, Inc.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 8- tagApproval40 co-mentions · 13 sources
- drugMaxtrex39 co-mentions · 18 sources
- drugMethotrexate Intas39 co-mentions · 18 sources
- drugMethotrexate Teva39 co-mentions · 18 sources
- drugMETHOTREXATE SODIUM32 co-mentions · 11 sources
- tagOncology4 co-mentions · 2 sources
- tagDrug Shortage3 co-mentions · 3 sources
- companyCity of Hope1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 15 approved and 79 investigational indications.
targets
Dihydrofolate reductase
all catalysts(0)
nothing on the calendar yet
Trials studying METHOTREXATE
- phase2Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
- phase2A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- phase2Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
- phase2Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- phase2A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
- phase4A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
- phase2A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
- phase3A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
News(2)
- Crystalys mines $130M series B to push gout drug through phase 3Crystalys Therapeutics has raised $130 million in series B financing to advance the development of its gout drug dotinurad and prepare for a potential commercial launch.fiercebiotech · 4mo ago
- Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placeRestricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.stat · 6mo ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that